iifl-logo

Beta Drugs Ltd Board Meeting

Add as a Preferred Source on Google
1,400.2
(2.30%)
May 26, 2026|05:30:00 AM

Beta Drugs Ltd CORPORATE ACTIONS

27/05/2025calendar-icon
27/05/2026calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting25 May 202625 May 2026
Beta Drugs Limited has informed the Exchange regarding Outcome of Board Meeting held on May 25, 2026.
Board Meeting14 May 202611 May 2026
Financial Results
Board Meeting25 Apr 202625 Apr 2026
Beta Drugs Limited has informed the Exchange regarding Outcome of Board Meeting held on April 25, 2026.
Board Meeting14 Feb 202610 Feb 2026
Financial Results Beta Drugs Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025. (As Per NSE Announcement Dated on : 14.02.2026)
Board Meeting9 Jan 20266 Jan 2026
To consider other business matters (a) acquisition of equity shares of a target company from certain shareholders of the target company; (b) issue certain equity shares to the shareholders of the target company on a preferential basis through the private placement route, as consideration other than cash in lieu of the acquired shares and(c) to consider and approve the Employee Stock Option Plan (ESOP).
Board Meeting29 Nov 202529 Nov 2025
Beta Drugs Limited has informed the Exchange regarding Board meeting held on November 29, 2025.
Board Meeting6 Nov 20251 Nov 2025
To consider and approve the financial results for the period ended September 30, 2025 Beta Drugs Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025. (As Per NSE Announcement Dated On : 06.11.2025)
Board Meeting3 Sep 20253 Sep 2025
Beta Drugs Limited has informed the Exchange regarding Board meeting held on September 03, 2025.

Beta Drugs Ltd: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.